According to the Zhitong Finance App, Runmed-B (02297.HK) announced interim results for the six months ended June 30, 2026. The group achieved revenue of 146.72 million yuan during the period, an increase of 41.01% over the previous year; losses attributable to the company's shareholders were 21.989 million yuan, a year-on-year decrease of 31.65%; and a basic loss of 0.02 yuan per share.

According to the Zhitong Finance App, Runmed-B (02297.HK) announced interim results for the six months ended June 30, 2026. The group achieved revenue of 146.72 million yuan during the period, an increase of 41.01% over the previous year; losses attributable to the company's shareholders were 21.989 million yuan, a year-on-year decrease of 31.65%; and a basic loss of 0.02 yuan per share.